<DOC>
	<DOCNO>NCT02106858</DOCNO>
	<brief_summary>To investigate collect post-marketing data safety Stivarga real world practice register indication ( ) require Health Authority .</brief_summary>
	<brief_title>Stivarga Regulatory Post-Marketing Surveillance Study Korea</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Patients diagnose metastatic colorectal cancer metastatic unresectable locally advanced GIST ( gastrointestinal stromal tumor ) physician . Patients prescribe Stivarga first time . All contraindication accord local marketing authorization consider .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Stivarga / Regorafenib / Metastatic Colorectal Cancer / Metastatic unresectable locally advanced GIST ( Gastrointestinal stromal tumor )</keyword>
</DOC>